1,7-phenanthroline has been researched along with Adenocarcinoma of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Liu, J; Wang, S; Wang, Y; Wu, Y; Zhang, W; Zhao, X | 1 |
| Chen, L; Chen, T; He, QY; Liu, J; Liu, Y; Yang, X; Yang, Y; Zheng, W | 1 |
2 other study(ies) available for 1,7-phenanthroline and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Synthesis and the interaction of 2-(1H-pyrazol-4-yl)-1H-imidazo[4,5-f][1,10]phenanthrolines with telomeric DNA as lung cancer inhibitors.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Cell Proliferation; G-Quadruplexes; Humans; Lung; Lung Neoplasms; Phenanthrolines; Pyrazoles; Telomere | 2017 |
Ruthenium methylimidazole complexes induced apoptosis in lung cancer A549 cells through intrinsic mitochondrial pathway.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Coordination Complexes; Gene Expression; Humans; Imidazoles; Lung Neoplasms; Membrane Potential, Mitochondrial; Mitochondria; Phenanthrolines; Proto-Oncogene Proteins c-bcl-2; Ruthenium; Signal Transduction | 2012 |